SomnoMed (ASX:SOM) ROE % Adjusted to Book Value : -26.67% (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is SomnoMed ROE % Adjusted to Book Value?

SomnoMed's ROE % for the quarter that ended in Dec. 2023 was -48.54%. SomnoMed's PB Ratio for the quarter that ended in Dec. 2023 was 1.82. SomnoMed's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -26.67%.

SomnoMed ROE % Adjusted to Book Value Historical Data

The historical data trend for SomnoMed's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed ROE % Adjusted to Book Value Chart

SomnoMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-12.91

-1.56

-0.67

-4.33

-9.51

SomnoMed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-2.88	-3.06	-6.66	-10.71	-26.67

Competitive Comparison of SomnoMed's ROE % Adjusted to Book Value

For the Medical Devices subindustry, SomnoMed's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SomnoMed's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SomnoMed's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where SomnoMed's ROE % Adjusted to Book Value falls into.

SomnoMed ROE % Adjusted to Book Value Calculation

SomnoMed's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-31.87%	/	3.35
	=	-9.51%

SomnoMed's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-48.54%	/	1.82
	=	-26.67%

SomnoMed ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of SomnoMed's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

SomnoMed (ASX:SOM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (ASX:SOM) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

SOMNF:USA RJV:Germany

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed (ASX:SOM) Headlines

No Headlines